Medistim ASA (OSL:MEDI)
227.00
0.00 (0.00%)
Jun 12, 2026, 4:25 PM CET
Medistim ASA Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Medistim ASA stock has a consensus rating of "Strong Buy" and an average price target of kr 315.00. The average 1-year stock price forecast is 38.77% higher than the current stock price, while the lowest is kr 310.00 (+36.56%) and the highest is kr 320.00 (+40.97%).
Price Target: kr 315.00 (+38.77%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Medistim ASA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
764.00M
from 699.77M
Increased by 9.18%
Revenue Next Year
827.00M
from 764.00M
Increased by 8.25%
EPS This Year
9.13
from 8.71
Increased by 4.82%
EPS Next Year
9.80
from 9.13
Increased by 7.28%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NOK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 764.0M | ||
| Avg | 764.0M | ||
| Low | 764.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.2% | ||
| Avg | 9.2% | ||
| Low | 9.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.13 | ||
| Avg | 9.13 | ||
| Low | 9.13 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.8% | ||
| Avg | 4.8% | ||
| Low | 4.8% |